PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
AACT 109 Target Disease Inflammation 252,734 2 0.00 -0.99 0.02 0.54
AACT 109 Target Disease Leukemia 162,805 2 0.00 -0.99 0.02 0.55
AACT 109 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.01 0.56
AACT 109 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.55
AACT 109 Target Disease Lung Carcinoma 13,423 1 0.00 -1.00 0.01 0.59
AACT 109 Target Disease Menopause 19,680 1 0.00 -1.00 0.01 0.58
AACT 109 Target Disease Pain 409,851 2 0.00 -0.99 0.02 0.53
AACT 109 Target Disease Sepsis 64,798 1 0.00 -1.00 0.01 0.55
AACT 109 Target Disease Shock 134,031 1 0.00 -1.00 0.01 0.54
AACT 109 Target Target Toll-Like Receptor 2 2,174 1 0.00 -1.00 0.01 0.64
ACAD8 11 Target Target APOE 12,771 1 0.00 -0.95 0.09 0.63
ACAD8 11 Target Disease Anemia 81,663 1 0.00 -0.95 0.09 0.59
ACAD8 11 Target Disease Cholesterol 182,390 1 0.00 -0.95 0.09 0.57
ACAD8 11 Target Disease Dehydration 21,928 1 0.00 -0.95 0.09 0.62
ACAD8 11 Target Disease Prostate Cancer 71,064 1 0.00 -0.95 0.09 0.59
ACAT2 145 Target Target APOA1 958 3 0.01 -0.99 0.02 0.70
ACAT2 145 Target Target APOE 12,771 7 0.01 -0.98 0.05 0.64
ACAT2 145 Target Disease Arthritis 128,324 1 0.00 -1.00 0.01 0.53
ACAT2 145 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
ACAT2 145 Target Disease Cholesterol 182,390 122 0.02 -0.40 0.84 0.65
ACAT2 145 Target Disease Down Syndrome 10,290 1 0.00 -1.00 0.01 0.59
ACAT2 145 Target Disease Dyslipidemia 15,225 2 0.00 -0.99 0.01 0.60
ACAT2 145 Target Target FABP1 90 1 0.01 -0.99 0.01 0.74
ACAT2 145 Target Disease Heart Disease 118,291 5 0.00 -0.98 0.03 0.57
ACAT2 145 Target Disease Hepatitis 163,842 1 0.00 -1.00 0.01 0.53
ACAT2 145 Target Disease Hyperlipidemia 15,317 5 0.00 -0.98 0.03 0.63
ACAT2 145 Target Disease Infertility 35,448 1 0.00 -1.00 0.01 0.56
ACAT2 145 Target Disease Inflammation 252,734 1 0.00 -1.00 0.01 0.52
ACAT2 145 Target Disease Liver Disease 49,817 2 0.00 -0.99 0.01 0.57
ACAT2 145 Target Disease Lung Cancer 91,416 2 0.00 -0.99 0.01 0.56
ACAT2 145 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.01 0.59
ACAT2 145 Target Disease Pain 409,851 1 0.00 -1.00 0.01 0.51
ACAT2 145 Target Target Peroxisome Proliferator-Activated Receptor Delta 355 1 0.00 -1.00 0.01 0.70
ACAT2 145 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.01 0.54
ACAT2 145 Target Target Sphingomyelinase 3,060 1 0.00 -1.00 0.01 0.63
ACRP30 102 Target Target APOE 12,771 3 0.00 -0.99 0.03 0.62
ACRP30 102 Target Target Adiponectin 11,994 72 0.07 -0.54 0.71 0.73
ACRP30 102 Target Disease Anorexia Nervosa 9,687 2 0.00 -0.99 0.02 0.62
ACRP30 102 Target Disease Arthritis 128,324 2 0.00 -0.99 0.02 0.55
ACRP30 102 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
ACRP30 102 Target Target CD4 112,219 1 0.00 -1.00 0.01 0.54
ACRP30 102 Target Disease Cancer 1,053,491 4 0.00 -0.98 0.04 0.53
ACRP30 102 Target Disease Carcinoma 433,099 1 0.00 -1.00 0.01 0.52
ACRP30 102 Target Disease Cholesterol 182,390 9 0.00 -0.95 0.09 0.58
ACRP30 102 Target Disease Chronic Obstructive Pulmonary Disease 27,780 2 0.00 -0.99 0.02 0.59
ACRP30 102 Target Target Collagen 138,882 7 0.00 -0.97 0.07 0.58
ACRP30 102 Target Disease Diabetes 332,602 27 0.00 -0.86 0.26 0.59
ACRP30 102 Target Disease Dyslipidemia 15,225 2 0.00 -0.99 0.02 0.61
ACRP30 102 Target Target EGF 27,487 1 0.00 -1.00 0.01 0.57
ACRP30 102 Target Target ERK1 18,374 4 0.00 -0.98 0.04 0.62
ACRP30 102 Target Disease Glioblastoma 17,933 1 0.00 -1.00 0.01 0.58
ACRP30 102 Target Target Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 1 0.00 -1.00 0.01 0.61
ACRP30 102 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.01 0.54
ACRP30 102 Target Disease Hyperglycemia 28,168 3 0.00 -0.99 0.03 0.60
ACRP30 102 Target Disease Hyperlipidemia 15,317 2 0.00 -0.99 0.02 0.61
ACRP30 102 Target Disease Infection 766,637 1 0.00 -1.00 0.01 0.50
ACRP30 102 Target Disease Inflammation 252,734 5 0.00 -0.98 0.05 0.56
ACRP30 102 Target Disease Liver Disease 49,817 3 0.00 -0.99 0.03 0.59
ACRP30 102 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.55
ACRP30 102 Target Disease Non Insulin Dependent Diabetes Mellitus 6,686 1 0.00 -1.00 0.01 0.61
ACRP30 102 Target Disease Obesity 138,233 34 0.01 -0.82 0.33 0.62
ACRP30 102 Target Disease Renal Failure 73,993 2 0.00 -0.99 0.02 0.57
ACRP30 102 Target Target Renin 43,456 1 0.00 -1.00 0.01 0.56
ACRP30 102 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -0.99 0.02 0.57
ACT-2 127 Target Target APOE 12,771 1 0.00 -1.00 0.01 0.59
ACT-2 127 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
ACT-2 127 Target Target BRAF 4,766 1 0.00 -1.00 0.01 0.62
ACT-2 127 Target Target Bivalirudin 891 1 0.00 -1.00 0.01 0.67
ACT-2 127 Target Disease Cardiac Arrest 20,700 1 0.00 -1.00 0.01 0.58
ACT-2 127 Target Disease Contraception 21,402 1 0.00 -1.00 0.01 0.58
ACT-2 127 Target Target D(2) Dopamine Receptor 1,559 1 0.00 -1.00 0.01 0.65
ACT-2 127 Target Disease Disabilities 28,757 2 0.00 -0.99 0.02 0.59
ACT-2 127 Target Disease HIV/AIDS 20,397 1 0.00 -1.00 0.01 0.58
ACT-2 127 Target Disease Histoplasmosis 4,583 1 0.00 -1.00 0.01 0.62
ACT-2 127 Target Disease Inflammation 252,734 2 0.00 -0.99 0.02 0.54
ACT-2 127 Target Disease Leukemia 162,805 2 0.00 -0.99 0.02 0.55
ACT-2 127 Target Disease Malaria 56,215 2 0.00 -0.99 0.02 0.57
ACT-2 127 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.01 0.59
ACT-2 127 Target Disease Pain 409,851 1 0.00 -1.00 0.01 0.51
ACT-2 127 Target Disease Shock 134,031 1 0.00 -1.00 0.01 0.53
ACTG1 41 Target Target AHSG 176 1 0.01 -0.98 0.02 0.74
ACTG1 41 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -0.99 0.02 0.63
ACTG1 41 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.99 0.02 0.61
ACTG1 41 Target Target B2M 677 1 0.01 -0.99 0.02 0.69
ACTG1 41 Target Disease Breast Cancer 173,695 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Target CALR 117 1 0.01 -0.98 0.02 0.76
ACTG1 41 Target Disease Disabilities 28,757 1 0.00 -0.99 0.02 0.59
ACTG1 41 Target Disease Hepatitis 163,842 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Hepatitis B 57,815 1 0.00 -0.99 0.02 0.57
ACTG1 41 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
ACTG1 41 Target Disease Inflammation 252,734 1 0.00 -0.99 0.02 0.54
ACTG1 41 Target Disease Leukemia 162,805 2 0.00 -0.98 0.05 0.57
ACTG1 41 Target Disease Muscle Weakness 9,178 2 0.00 -0.98 0.05 0.64
ACTG1 41 Target Disease Retinitis 9,116 1 0.00 -0.99 0.02 0.62
ACTG1 41 Target Disease Shock 134,031 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Tuberculosis 146,217 1 0.00 -0.99 0.02 0.55
ACVR1B 23 Target Target Activin A 2,048 5 0.02 -0.88 0.22 0.72
ACVR1B 23 Target Disease Asthma 109,610 1 0.00 -0.98 0.04 0.57
ACVR1B 23 Target Target BMPR1A 279 2 0.02 -0.95 0.09 0.76
ACVR1B 23 Target Disease Breast Cancer 173,695 1 0.00 -0.98 0.04 0.56